|
1
|
DeLise AM, Fischer L and Tuan RS: Cellular
interactions and signaling in cartilage development. Osteoarthritis
Cartilage. 8:309–334. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sandell LJ and Adler P: Developmental
patterns of cartilage. Front Biosci. 4:D731–D742. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sandell LJ and Aigner T: Articular
cartilage and changes in arthritis. An introduction: cell biology
of osteoarthritis. Arthritis Res. 3:107–113. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Feldmann M: Pathogenesis of arthritis:
recent research progress. Nat Immunol. 2:771–773. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Feldmann M, Brennan FM and Maini RN:
Rheumatoid arthritis. Cell. 85:307–310. 1996. View Article : Google Scholar
|
|
6
|
Erdèlyi K, Kiss A, Bakondi E, Bai P, Szabó
C, Gergely P, Erdödi F and Virag L: Gallotannin inhibits the
expression of chemokines and inflammatory cytokines in A549 cells.
Mol Pharmacol. 68:895–904. 2005.PubMed/NCBI
|
|
7
|
Li W, Zhang J, Flechner L, Hyun T, Yam A,
Franke TF and Pierce JH: Protein kinase C-alpha overexpression
stimulates Akt activity and suppresses apoptosis induced by
interleukin 3 withdrawal. Oncogene. 18:6564–6572. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rapizzi E, Fossati S, Moroni F and
Chiarugi A: Inhibition of poly(ADP-ribose) glycohydrolase by
gallotannin selectively up-regulates expression of proinflammatory
genes. Mol Pharmacol. 66:890–898. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Feldman KS, Sahasrabudhe K, Lawlor MD,
Wilson SL, Lang CH and Scheuchenzuber WJ: In vitro and in vivo
inhibition of LPS-stimulated tumor necrosis factor-alpha secretion
by the gallotannin beta-D-pentagalloylglucose. Bioorg Med Chem
Lett. 11:1813–1815. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hagerman AE, Riedl KM and Rice RE: Tannins
as biological antioxidants. Basic Life Sci. 66:495–505.
1999.PubMed/NCBI
|
|
11
|
Smith WL, DeWitt DL and Garavito RM:
Cyclooxygenases: structural, cellular, and molecular biology. Annu
Rev Biochem. 69:145–182. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dubois RN, Abramson SB, Crofford L, Gupta
RA, Simon LS, Van De Putte LB and Lipsky PE: Cyclooxygenase in
biology and disease. FASEB J. 12:1063–1073. 1998.PubMed/NCBI
|
|
13
|
Wu KK: Inducible cyclooxygenase and nitric
oxide synthase. Adv Pharmacol. 33:179–207. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Goldring MB and Berenbaum F: Human
chondrocyte culture models for studying cyclooxygenase expression
and prostaglandin regulation of collagen gene expression.
Osteoarthritis Cartilage. 7:386–388. 1999. View Article : Google Scholar
|
|
15
|
Namkoong S, Lee SJ, Kim CK and Kim YM,
Chung HT, Lee H, Han JA, Ha KS, Kwon YG and Kim YM: Prostaglandin
E2 stimulates angiogenesis by activating the nitric oxide/cGMP
pathway in human umbilical vein endothelial cells. Exp Mol Med.
37:588–600. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Smith WL, Garavito RM and DeWitt DL:
Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2.
J Biol Chem. 271:33157–33160. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Okada Y, Lorenzo JA, Freeman AM, Tomita M,
Morham SG, Raisz LG and Pilbeam CC: Prostaglandin G/H synthase-2 is
required for maximal formation of osteoclast-like cells in culture.
J Clin Invest. 105:823–832. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Suponitzky I and Weinreb M: Differential
effects of systemic prostaglandin E2 on bone mass in rat long bones
and calvariae. J Endocrinol. 156:51–57. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Weinreb M, Suponitzky I and Keila S:
Systemic administration of an anabolic dose of PGE2 in
young rats increases the osteogenic capacity of bone marrow. Bone.
20:521–526. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Duncan RL and Turner CH:
Mechanotransduction and the functional response of bone to
mechanical strain. Calcif Tissue Int. 57:344–358. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Forwood MR: Inducible cyclo-oxygenase
(COX-2) mediates the induction of bone formation by mechanical
loading in vivo. J Bone Miner Res. 11:1688–1693. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Park EH, Kang SS, Lee YS, Kim SJ, Jin EJ,
Tak EN and Sonn JK: Integrity of the cortical actin ring is
required for activation of the PI3K/Akt and p38 MAPK signaling
pathways in redifferentiation of chondrocytes on chitosan. Cell
Biol Int. 32:1272–1278. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim SJ, Kim HG, Oh CD, Hwang SG, Song WK,
Yoo YJ, Kang SS and Chun JS: p38 kinase-dependent and -independent
Inhibition of protein kinase C zeta and -alpha regulates nitric
oxide-induced apoptosis and dedifferentiation of articular
chondrocytes. J Biol Chem. 277:30375–30381. 2002. View Article : Google Scholar
|
|
24
|
Kim SJ, Ju JW, Oh CD, Yoon YM, Song WK,
Kim JH, Yoo YJ, Bang OS, Kang SS and Chun JS: ERK-1/2 and p38
kinase oppositely regulate nitric oxide-induced apoptosis of
chondrocytes in association with p53, caspase-3, and
differentiation status. J Biol Chem. 277:1332–1339. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yoon YM, Kim SJ, Oh CD, Ju JW, Song WK,
Yoo YJ, Huh TL and Chun JS: Maintenance of differentiated phenotype
of articular chondrocytes by protein kinase C and extracellular
signal-regulated protein kinase. J Biol Chem. 277:8412–8420. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ryu JH, Kim SJ, Kim SH, Oh CD, Hwang SG,
Chun CH, Oh SH, Seong JK, Huh TL and Chun JS: Regulation of the
chondrocyte phenotype by beta-catenin. Development. 129:5541–5550.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lü L, Liu SW, Jiang SB and Wu SG: Tannin
inhibits HIV-1 entry by targeting gp41. Acta Pharmacol Sin.
25:213–218. 2004.PubMed/NCBI
|
|
28
|
Lu Y, Jiang F, Jiang H, Wu K, Zheng X, Cai
Y, Katakowski M, Chopp M and To SS: Gallic acid suppresses cell
viability, proliferation, invasion and angiogenesis in human glioma
cells. Eur J Pharmacol. 641:102–107. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Akiyama H, Fujii K, Yamasaki O, Oono T and
Iwatsuki K: Antibacterial action of several tannins against
Staphylococcus aureus. J Antimicrob Chemother. 48:487–491.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yu SM, Gweon EJ, Chung KW, Kim KH, Cho HS
and Kim SJ: Gallotannin regulates apoptosis and COX-2 expression
via Akt and p38kinase pathway in human lung cancer cell line, A549.
Animal Cells and Systems. 16:366–375. 2012. View Article : Google Scholar
|
|
31
|
Keller J: Effects of indomethacin and
local prostaglandin E2 on fracture healing in rabbits. Dan Med
Bull. 43:317–329. 1996.PubMed/NCBI
|
|
32
|
Norrdin RW and Shih MS: Systemic effects
of prostaglandin E2 on vertebral trabecular remodeling in beagles
used in a healing study. Calcif Tissue Int. 42:363–368. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Amin AR, Dave M, Attur M and Abramson SB:
COX-2, NO, and cartilage damage and repair. Curr Rheumatol Rep.
2:447–453. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Schwartz Z, Gilley RM, Sylvia VL, Dean DD
and Boyan BD: The effect of prostaglandin E2 on costochondral
chondrocyte differentiation is mediated by cyclic adenosine
3′,5′-monophosphate and protein kinase C. Endocrinology.
139:1825–1834. 1998.PubMed/NCBI
|
|
35
|
Abramson SB: The role of COX-2 produced by
cartilage in arthritis. Osteoarthritis Cartilage. 7:380–381. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Goldring MB, Birkhead JR, Suen LF, Yamin
R, Mizuno S, Glowacki J, Arbiser JL and Apperley JF: Interleukin-1
beta-modulated gene expression in immortalized human chondrocytes.
J Clin Invest. 94:2307–2316. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Goldring MB, Suen LF, Yamin R and Lai WF:
Regulation of collagen gene expression by prostaglandins and
interleukin-1beta in cultured chondrocytes and fibroblasts. Am J
Ther. 3:9–16. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lee WK, Yu SM, Cheong SW, Sonn JK and Kim
SJ: Ectopic expression of cyclooxygenase-2-induced
dedifferentiation in articular chondrocytes. Exp Mol Med.
40:721–727. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kim MS, Park SB, Suk K, Kim IK, Kim SY,
Kim JA, Lee SH and Kim SH: Gallotannin isolated from Euphorbia
species, 1,2,6-tri-O-galloyl-beta-D-allose, decreases nitric oxide
production through inhibition of nuclear factor-kappa B and
downstream inducible nitric oxide synthase expression in
macrophages. Biol Pharm Bull. 32:1053–1056. 2009. View Article : Google Scholar
|
|
40
|
Widmann C, Gibson S, Jarpe MB and Johnson
GL: Mitogen- activated protein kinase: conservation of a
three-kinase module from yeast to human. Physiol Rev. 79:143–180.
1999.PubMed/NCBI
|
|
41
|
Zhang W and Liu HT: MAPK signal pathways
in the regulation of cell proliferation in mammalian cells. Cell
Res. 12:9–18. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Houde M, Laprise P, Jean D, Blais M,
Asselin C and Rivard N: Intestinal epithelial cell differentiation
involves activation of p38 mitogen-activated protein kinase that
regulates the homeobox transcription factor CDX2. J Biol chem.
276:21885–21894. 2001. View Article : Google Scholar
|
|
43
|
Guan Z, Buckman SY, Miller BW, Springer LD
and Morrison AR: Interleukin-1beta-induced cyclooxygenase-2
expression requires activation of both c-Jun NH2-terminal kinase
and p38 MAPK signal pathways in rat renal mesangial cells. J Biol
Chem. 273:28670–28676. 1998. View Article : Google Scholar
|
|
44
|
Matsuura H, Sakaue M, Subbaramaiah K,
Kamitani H, Eling TE, Dannenberg AJ, Tanabe T, Inoue H, Arata J and
Jetten AM: Regulation of cyclooxygenase-2 by interferon gamma and
transforming growth factor alpha in normal human epidermal
keratinocytes and squamous carcinoma cells. Role of
mitogen-activated protein kinases. J Biol Chem. 274:29138–29148.
1999. View Article : Google Scholar
|
